Health care products company Johnson & Johnson said Monday it will buy cosmetic-product and breast-implant maker Mentor Corp. for $1.07 billion in a move to boost its presence in cosmetic and reconstructive medicine.
Santa Barbara, Calif.-based Mentor has a unit in University Research Park in Madison that is developing a drug to compete with the well-known and hugely successful Botox.